foxo4-dri senolytic 2023 The disordered p53 transactivation domain is the target of FOXO4 and the compound Development of a novel senolytic
Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect FOXO4 DRI 2460055 10 9 AdooQ foxo4 dri peptide senolytic mouse study 2023 Molecular modelling of the FOXO4 TP53 interaction to design FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data
Pay in 4 interest-free payments of $7.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




